Management of COVID-19 infection in organic acidemias

Shagun Kaur1, Stephanie L Campbell1, David W Stockton1,2

  • 1Division of Genetic, Genomic, and Metabolic Disorders, Children's Hospital of Michigan, Detroit, Michigan, USA.

Insights

COVID-19 infection can cause metabolic decompensation in children with inborn errors of metabolism (IEM). SARS-CoV-2 did not worsen metabolic decline beyond typical expectations for these patients.

Area of Science:

  • Infectious Diseases
  • Metabolic Disorders
  • Pediatric Health

Background:

  • The COVID-19 pandemic has had a global impact on health, with pediatric cases generally showing milder symptoms.
  • Limited research exists on Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) infections in children with inborn errors of metabolism (IEM).

Observation:

  • This report details two pediatric patients with underlying metabolic disorders: propionic acidemia and glutaric aciduria type 1.
  • The patients' clinical presentations, infectious disease management, and metabolic care during SARS-CoV-2 infection are discussed.

Findings:

  • Individuals with IEM are susceptible to metabolic decompensation when infected with SARS-CoV-2.
  • The severity of metabolic deterioration from SARS-CoV-2 infection in these patients was consistent with their typical metabolic challenges.

Implications:

  • Children with inborn errors of metabolism require careful monitoring for metabolic decompensation during COVID-19 infections.
  • Understanding the interaction between SARS-CoV-2 and IEM is crucial for effective clinical management and patient outcomes.

Related Concept Videos

Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and...
778
Disorders of Acid-Base Balance01:29

Disorders of Acid-Base Balance

The human body maintains a precise pH range of arterial blood between 7.35 and 7.45. Deviations result in either acidosis (pH < 7.35) or alkalosis (pH > 7.45). These conditions are further classified as respiratory or metabolic disorders based on their underlying cause.
Respiratory Acidosis and Alkalosis
Respiratory acidosis occurs due to an increase in the partial pressure of carbon dioxide PCO2 in the blood. It often arises from shallow breathing or impaired gas exchange caused by...
1.5K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
288
Acid-Base Balance01:25

Acid-Base Balance

The human body maintains a narrow pH range regulated through acid-base balance. This balance is crucial as changes in the hydrogen ion concentration can disrupt cell membrane stability, alter protein structures, and change enzyme activities. The normal pH of arterial blood is 7.4, venous blood and interstitial fluid is 7.35, and intracellular fluid averages 7.0.
When the pH of arterial blood rises above 7.45, it results in a condition called alkalosis. Conversely, a drop below 7.35 leads to...
1.8K
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
2.6K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
310